The Spain-headquartered company presented the ingredient, Adifyline, to the industry at this year’s in-cosmetics in Milan.
By acting on a receptor involved in adipogenesis called PGC-1 alpha, Adifyline can enhance the rate of lipid accumulation, marketing manager for the company Elena Canadas explained.
“The ingredient enhances the rate of the adipocyte differentiation, from pre-adipocytes to adipocytes,” she told CosmeticsDesign-Europe.com at the show. The result is an enhanced accumulation of lipids and therefore increased volume where applied, she added.
Increased volume in cheeks and breasts
The company tested the ingredient on both the cheeks and the bust area, and claims that its volume increasing effects in both areas are visible.
“We performed an in vivo test on the cheek area in 22 females aged between 50 and 60. At this age the menopause has caused the fat in these areas to decrease,” Canadas said.
According to the company’s tests, after 14 days of twice daily application, there was an increase in the volume of the cheek area.
An in vivo test on the bust area was performed with 22 females between 25 and 40 with bra sizes of between 80 and 90, she said.
The volunteers applied a product containing the ingredient twice daily for 56 days, and measurements were taken after 14, 28 and 56 days, Canadas explained.
An increase in volume was measured after 14 days, with visible differences at 56 days, Canadas said.
A hexapeptide, the ingredient is part of the company’s Aimtec product line which comprises of peptides and organic molecules that have been designed to stimulate, inhibit or compete with specific targets in the skin.